Concepedia

Steve Fidanze

SF

Statistics

Publications

17

Citations

1.4K

H-Index

16

Active since

1997

Affiliations

University of Illinois Chicago(Current)

Harvard University

AbbVie (United States)

Abbott Fund

Abbott (United States)

Steve Fidanze is an author at University of Illinois Chicago specializing in medicinal chemistry, drug discovery, and chemistry.

Publications per year

1997–2020

17

Publications

17

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 404 citations

, , +10

Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

Milan Bruncko, Le Wang, George S. Sheppard et al. · Journal of Medicinal Chemistry · 2015 · 152 citations · Full text

, , +14

Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies

Mai H. Bui, Daniel H. Albert, Leiming Li et al. · Cancer Research · 2017 · 119 citations

, , +17

Stereochemistry of the Core Structure of the Mycolactones

Andrew B. Benowitz, Steve Fidanze, Pamela L. C. Small et al. · Journal of the American Chemical Society · 2001 · 87 citations

, , +8

Complete Structure of the Mycolactones

Steve Fidanze, Fengbin Song, Magali Szlosek‐Pinaud et al. · Journal of the American Chemical Society · 2001 · 87 citations

, , +9

1–5 of 17